Đang chuẩn bị liên kết để tải về tài liệu:
A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Local or distant relapse is the key event for the overall survival of early-stage breast cancer after initial surgery. A small subset of breast cancer cells, which share similar properties with normal stem cells, has been proven to resist to clinical therapy contributing to recurrence. | A multiple breast cancer stem cell model to predict recurrence of T1 3 N0 breast cancer

TÀI LIỆU LIÊN QUAN

A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer

Metastatic breast cancer patient perceptions of somatic tumor genomic testing

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer

Cisplatin-resistant triple-negative breast cancer subtypes: Multiple mechanisms of resistance

A prospective investigation of oral contraceptive use and breast cancer mortality: Findings from the Swedish women’s lifestyle and health cohort

LGR5 overexpression confers poor relapse-free survival in breast cancer patients

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

Family history of breast cancer as a second primary malignancy in relatives: A nationwide cohort study

Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression